Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Carnosine

Generic Name: Carnosine

Drug Type: Small Molecule

Chemical Formula: C_₉H_₁₄N_₄O_₃

CAS Number: 305-84-0

Unique Ingredient Identifier: 8HO6PVN24W

Overview

Carnosine has been investigated for the treatment of Gulf War Illness.

Background

Carnosine has been investigated for the treatment of Gulf War Illness.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

Phase 1

Recruiting

Posted: 2024/06/28

Sponsor:

Shahid Baba

ID:NCT06480760

Carnosine for Peripheral Arterial Disease

Phase 2

Completed

Posted: 2021/05/03

Sponsor:University of Louisv...

ID:NCT04870229

Carnosine for Peripheral Vascular Disease

Phase 2

Posted: 2019/02/18

Sponsor:Monash University

ID:NCT03844113

L-carnosine Prophylactic Effect on Oxaliplatin Induced Peripheral Neuropathy in GIT Cancer Patients

Phase 1

Completed

Posted: 2016/06/22

Sponsor:Cairo University

ID:NCT02808624

Carnosine and Cognitive Training in Schizophrenia

Phase 2

Completed

Posted: 2016/02/19

Sponsor:

Abraham Reichenberg

ID:NCT02686697

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy